LGCRX
Price
$18.97
Change
+$0.06 (+0.32%)
Updated
Jul 25 closing price
Net Assets
234.84M
RWIGX
Price
$72.50
Change
+$0.04 (+0.06%)
Updated
Jul 25 closing price
Net Assets
137.34B
Interact to see
Advertisement

LGCRX vs RWIGX

Header iconLGCRX vs RWIGX Comparison
Open Charts LGCRX vs RWIGXBanner chart's image
Lord Abbett Global Equity R3
Price$18.97
Change+$0.06 (+0.32%)
VolumeN/A
Net Assets234.84M
American Funds Capital World Gr&Inc R6
Price$72.50
Change+$0.04 (+0.06%)
VolumeN/A
Net Assets137.34B
LGCRX vs RWIGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LGCRX vs. RWIGX commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGCRX is a Buy and RWIGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIGX has more cash in the bank: 137B vs. LGCRX (235M). RWIGX pays higher dividends than LGCRX: RWIGX (1.77) vs LGCRX (0.14). LGCRX was incepted earlier than RWIGX: LGCRX (9 years) vs RWIGX (16 years). LGCRX (1.97) is less costly to investors than RWIGX (0.41). LGCRX is a more actively managed with annual turnover of: 41.00 vs. RWIGX (27.00). LGCRX has a lower initial minimum investment than RWIGX: LGCRX (0) vs RWIGX (250). LGCRX annual gain was more profitable for investors over the last year : 20.10 vs. RWIGX (14.19). LGCRX return over 5 years is better than : 60.02 vs. RWIGX (53.12).
LGCRXRWIGXLGCRX / RWIGX
Total Expense Ratio1.150.41280%
Annual Report Gross Expense Ratio1.970.41480%
Fund Existence9 years16 years-
Gain YTD14.83115.23297%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets235M137B0%
Annual Yield % from dividends0.141.778%
Returns for 1 year20.1014.19142%
Returns for 3 years65.3752.36125%
Returns for 5 years60.0253.12113%
Returns for 10 yearsN/A65.19-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REFR1.840.03
+1.66%
Research Frontiers
WHLRD34.780.44
+1.29%
Wheeler Real Estate Investment Trust
DSGX107.671.22
+1.15%
Descartes Systems Group
RNST36.770.37
+1.02%
Renasant Corp
CTMX2.400.01
+0.42%
CytomX Therapeutics